Japan and Singapore have agreed to exchange confidential information on the regulation of drugs, medical devices and cosmetics1.
The two sides have a signed a confidentiality agreement under which they will exchange non-public information, such as advance drafts of legislation, regulatory guidance documents and data relating to the authorisation and supervision of medical products for human use, in accordance with their respective national laws and regulations...
Please login to read the full article.
